Edition:
India

Savara Inc (SVRA.OQ)

SVRA.OQ on NASDAQ Stock Exchange Global Select Market

12.59USD
20 Jul 2018
Change (% chg)

$-0.10 (-0.79%)
Prev Close
$12.69
Open
$12.66
Day's High
$13.20
Day's Low
$12.53
Volume
46,116
Avg. Vol
83,307
52-wk High
$17.11
52-wk Low
$5.07

Select another date:

Thu, May 10 2018

BRIEF-Savara Reports Q1 Loss Per Share $0.88

* SAVARA REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

BRIEF-Savara Reports Q4 Loss Per Share $0.23

* SAVARA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

BRIEF-Savara Initiates Phase 2A Clinical Study Of Molgradex For The Treatment Of Ntm Lung Infection

* SAVARA INITIATES PHASE 2A CLINICAL STUDY OF MOLGRADEX FOR THE TREATMENT OF NTM LUNG INFECTION Source text for Eikon: Further company coverage:

BRIEF-Savara Announces IND Approval For Expansion Of Molgradex Phase 3 Study Into U.S.

* SAVARA ANNOUNCES IND APPROVAL FOR EXPANSION OF MOLGRADEX PHASE 3 STUDY INTO U.S.

Select another date: